JCB logo
Sign up for e-mail content alerts
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online September 10, 2007
doi:10.1083/jcb.200701148
The Journal of Cell Biology, Vol. 178, No. 6, 1053-1064
The Rockefeller University Press, 0021-9525 $30.00
© 2007 Gil-Henn et al.
This Article
Right arrow Full Text
Right arrow PDF (Full Text)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gil-Henn, H.
Right arrow Articles by Schlessinger, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gil-Henn, H.
Right arrow Articles by Schlessinger, J.
Related Collections
Right arrowRelated Article
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Article

 Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2–/– mice

Hava Gil-Henn1, Olivier Destaing2, Natalie A. Sims2, Kazuhiro Aoki2,3, Neil Alles3, Lynn Neff2, Archana Sanjay2, Angela Bruzzaniti2, Pietro De Camilli2, Roland Baron2, and Joseph Schlessinger1

1 Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06511
2 Departments of Cell Biology and Orthopaedics, Yale University School of Medicine, New Haven, CT 06511
3 Department of Hard Tissue Engineering, Section of Pharmacology, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan

Correspondence to Joseph Schlessinger: joseph.schlessinger{at}yale.edu; or Roland Baron: roland.baron{at}yale.edu.

The protein tyrosine kinase Pyk2 is highly expressed in osteoclasts, where it is primarily localized in podosomes. Deletion of Pyk2 in mice leads to mild osteopetrosis due to impairment in osteoclast function. Pyk2-null osteoclasts were unable to transform podosome clusters into a podosome belt at the cell periphery; instead of a sealing zone only small actin rings were formed, resulting in impaired bone resorption. Furthermore, in Pyk2-null osteoclasts, Rho activity was enhanced while microtubule acetylation and stability were significantly reduced. Rescue experiments by ectopic expression of wild-type or a variety of Pyk2 mutants in osteoclasts from Pyk2–/– mice have shown that the FAT domain of Pyk2 is essential for podosome belt and sealing zone formation as well as for bone resorption. These experiments underscore an important role of Pyk2 in microtubule-dependent podosome organization, bone resorption, and other osteoclast functions.

H. Gil-Henn and O. Destaing contributed equally to this paper.

N.A. Sims' present address is St. Vincent's Institute, Fitzroy VIC 3065, Victoria, Australia.

K. Aoki's present address is Department of Hard Tissue Engineering, Section of Pharmacology, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan.

A. Sanjay's present address is Department of Anatomy and Cell Biology, Temple University School of Medicine, Philadelphia, PA 19140.

Abbreviations used in this paper: FAT, focal adhesion targeting; RBD, Rho binding domain.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Pyk2 for perfect bones
Nicole LeBrasseur
J. Cell Biol. 2007 178: 891. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents